Who founded Nautilus Biotechnology?

Nautilus Biotechnology was founded by Sujal Patel, Parag Mallick in 2020.

Who are Nautilus Biotechnology's investors?

Nautilus Biotechnology's investors include Andreessen Horowitz, Defy Partners, Madrona Venture Group, AME Cloud Ventures.

How much funding has Nautilus Biotechnology raised?

Nautilus Biotechnology has disclosed $276M raised across 2 rounds.

Where is Nautilus Biotechnology headquartered?

Nautilus Biotechnology is headquartered in Seattle, US.

Nautilus Biotechnology

NASDAQ: NAUT

Seattle, US · Founded 2020 · Delaware corporation · 151 employees on LinkedIn · 4 known investors

Find your way into Nautilus Biotechnology

Paths you didn't know you had: your email and LinkedIn already hold routes to the Nautilus Biotechnology team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nautilus develops proteomics technology to unlock the complexity of the human proteome for biomedical research and diagnostics. The company targets pharmaceutical, biotechnology, academic, clinical, and government sectors with advanced protein quantification and analysis platforms.

Biotech Deep Tech Medical Devices

Founders & leadership

Nautilus Biotechnology was founded in 2020 by Sujal Patel and Parag Mallick.

Sujal Patel FounderStrategic Director at Madrona Venture Group

Parag Mallick FounderTrained as an engineer and biochemist, Parag Mallick leads a Stanford research lab working on proteomics, computational and experimental systems biology, artificial intelligence, cancer biology, and nanotechnology, with a focus on disease mechanisms, biomarker discovery, and personalized medicine. He is co-founder and Chief Scientist of Nautilus Biotechnology, which develops a single-molecule protein analysis platform, and advises other biotechnology and diagnostics companies.

Melissa EpperlyExecutive

Nicholas NelsonExecutive

Subra Sankar SVP Product DevelopmentSubra Sankar has more than two decades of engineering and product development experience across life sciences, semiconductors, energy, and instrumentation sectors, with background in both startups and established organizations.

Matthew Murphy General CounselMatthew Murphy serves as an Executive Officer at Nautilus Biotechnology, which develops proteomics technology for biomedical research and diagnostics. He has held IP and general counsel roles at technology companies, with expertise in intellectual property strategy and legal operations for life science firms.

Anna Mowry CFOAnna Mowry is an Executive Officer at Nautilus Biotechnology, a proteomics company developing protein quantification and analysis platforms for research and diagnostics. She brings finance experience focused on organizational strategy and process development.

Board

Michael AltmanBoard director

Vijay Pande Member Board Of Directors2018–2025General Partner, Andreessen Horowitz at Propagator Ventures

Matthew S. McIlwain Board directorManaging Director at Madrona Venture Group

Farzad NazemBoard Member

Matthew PosardBoard director

Investors · 4

Andreessen Horowitzlisted by Andreessen HorowitzMenlo Park · $500K – $50Mvia Vijay Pande · board

How we know: a16z's portfolio · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us

Defy Partnerslisted by Defy PartnersWoodside · $3M – $10M

How we know: Defy Partners's portfolio page · the VCSheet dataset · Not right? Tell us

Madrona Venture Grouplisted by Madrona Venture GroupSeattle · $2M – $10M

How we know: Madrona Venture Group's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

AME Cloud VenturesreportedPalo Alto · $1M – $10M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$276M disclosed across 2 rounds · 2020–2021

$76MSeries BMay 2020 · 2 sources
Source ↗

▶$200MraisedJun 2021 · 38 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Melissa EpperlyDirector
Nicholas NelsonExecutive Officer
Subra SankarExecutive Officer
Farzad NazemDirector
Matthew MurphyExecutive Officer
Sujal PatelExecutive Officer, Director
Michael AltmanDirector
Vijay PandeDirector
Matthew PosardDirector
Anna MowryExecutive Officer
Matthew S. McIlwainDirector
Parag MallickExecutive Officer, Director

Offering amount: $200M
Amount sold: $200M
Sales commissions: $2M
Placement agents: Goldman Sachs & Co. LLC, Jefferies LLC
First sale: Jun 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

BYJU'SBYJU'S offers online learning programs, video lessons, and a personalized learning app for students in India, including tutoring and exam-preparation programs for competitive tests such as JEE and NEET.

BionityBionity.com is a German-language B2B trade portal for the life sciences, biotechnology, and pharmaceutical industries, offering news, trends, supplier directories, job listings, and lab and production solutions. Operated by LUMITOS AG, it serves professionals in industry, research, and science and provides online marketing services to reach this B2B audience.

Companies working in the same space as Nautilus Biotechnology.

In the news

Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome - BioSpacebiospace.com · May 2020

Frequently asked questions

What does Nautilus Biotechnology do?: Nautilus develops proteomics technology to unlock the complexity of the human proteome for biomedical research and diagnostics. The company targets pharmaceutical, biotechnology, academic, clinical, and government sectors with advanced protein quantification and analysis platforms.
Who founded Nautilus Biotechnology?: Nautilus Biotechnology was founded by Sujal Patel, Parag Mallick in 2020.
Who are Nautilus Biotechnology's investors?: Nautilus Biotechnology's investors include Andreessen Horowitz, Defy Partners, Madrona Venture Group, AME Cloud Ventures.
How much funding has Nautilus Biotechnology raised?: Nautilus Biotechnology has disclosed $276M raised across 2 rounds.
Where is Nautilus Biotechnology headquartered?: Nautilus Biotechnology is headquartered in Seattle, US.